Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: atorvastatin attending: chief complaint: dyspnea major surgical or invasive procedure: central venous line (subclavian) intubation history of present illness: 75 yo female with pmhx of dm, asthma, htn, hyperlipidemia who presented from her home with respiratory distress. on admission, she was found to have an o2 sat of 85% on ra, and was given nebs/iv lasix. her initial abg was 7.12/47/152/16 with lactate of 8, and cpap was initially begun in the ed. she was noted to be bradycardic, with a ?junctional escape rhythm at a rate of 48 bpm in the setting of hyperkalemia (k=7), and was given atropine. however, she subsequently became hypotensive, was started on dopamine, and was electively intubated. of note, several medications were apparently changed by her pcp, initiation of cardtia xt 300mg daily, with discontinuation of nifedipine. ed course also notable for empiric initiation of levofloxacin, vancomycin, flagyl, and hydrocortisone. micu course notable for resolution of her hyperkalemia, which was thought to be secondary to a combination acute on chronic renal failure and toxicity, with resolution of normal sinus rhythm (rate in the 70s), and pressors were waned off on hospital day one. her renal function improved, with cr 1.4 the morning of transfer to the floor (baseline 0.8 - 1.2). she was successfully extubated , though required intermittent noninvasive ventilation for hypercarbia thought to be secondary to combination of sedative medications and poor baseline respiratory status. she also was noted to be febrile, and was treated empirically for possible mrsa pneumonia (sputum cultures positive for mrsa), with defervescence on . furthermore, discussion with outpatient psychiatrist revealed that patient has atypical reaction (extreme agitation/?psychosis) to midazolam, which may have contributed to her altered mental status during weaning period. she was also noted to have hypernatremia, which was thought to be secondary to crystalloid given during initial fluid resuscitation in the setting of acute renal insufficiency. her hypernatremia improved with free water repletion. pmhx: htn, dm ii with neuropathy/nephropathy, asthma, increased lipids, ?parkinsonism, paranoid schizophrenia, bipolar disorder, obesity, osteoarthritis, gerd, bpd, diabetic neuropathy, r tkr, anemia, cri. diverticulitosis. ?hepatic cyst, s/p right total knee replacement (). past medical history: 1. status post right total knee replacement 2. dm ii, c/b neuropathy and nephropathy. 3. osteoarthritis. 4. hypertension. 5. asthma. 6. hypercholesterolemia. 7. parkinson's. 8. obesity. 9. gerd. 10. bipolar/paranoia. 11. history of falls. social history: shx: lives in an facility. no known h/o tobacco or alcohol use. family history: nc physical exam: vital signs: temp 98.4, bp 130/60, hr 84, rr 20, sao2 94% ra, last 4 fs in reverse order: 84, 62, 174, 98. gen: patient seated in the nursing area in chair, nad, awake&alert, nad cv: rrr nl s1 s2, no m/r/g appreciated pulm: scattered expiratory rhonchi throughout abd: obese, protruberant, nt, +bs ext: no edema cv: 2+ pt, dp pulses bilaterally neuro: awake, alert, oriented to person and place brief hospital course: micu course: * bradycardia/hypotension: bradycardia was thought to be secondary to either junctional rhythm vs. hyperkalemic arrhythmia, as potassium was >7 on admission. hyperkalemia was thought to be secondary to a combination acute on chronic renal failure and toxicity. following correction of hyperkalemia, patient returned to sinus rhythm with rate in the 70s. consequently, blood pressure normalized and patient was easily weaned off pressors on hospital day one. * respiratory distress: patient was initially intubated upon arrival given hemodynamic collapse. however, patient was not extubated until hospital day 3, as patient was noted to be extremely agitated during spontaneous breathing trials despite excellent objective indications of successful extubation (low rsbi, appropriate respiratory rates and tidal volumes). nonetheless, patient was successfully extubated, but required intermittent noninvasive ventilation for hypercarbia thought to be secondary to combination of sedative medications and baseline copd. discussion with outpatient psychiatrist revealed that patient has atypical reaction (extreme agitation/?psychosis) to midazolam, which may have explained patient's mental status during weaning period. * bacterial pneumonia: given above difficulty with extubation and intermittent fevers, sputum gram stain and cultures were sent, and patient was found to have mrsa pneumonia. prior to microbiological data, patient was empirically started on levofloxacin and metronidazole, but vancomycin was added following identification of staphylococcus aureus in sputum culture . this colony was later found to be oxacillin resistant, and patient was continued on vancomycin. patient was afebrile by third day of treatment, with low grade temperature elevations. * borderline personality disorder: according to outpatient psychiatrist, patient is easily agitated at baseline and is best managed by a combination of quetiapine, valproic acid, and oxazepam prn. following medical stabilization, patient was restarted on quetiapine and valproic acid with prn lorazepam for acute bouts of agitation. quetiapine was uptitrated as needed. nonetheless, patient continued to require 1:1 precautions - which outpatient psychiatrist felt would be expected at patient's baseline mental status. * hypernatremia: thought to be due to large sodium load during initial fluid resuscitation in the setting of acute renal insufficiency. patient was given a combination of free water boluses via ng tube and d5w to correct free water deficit 50%/day. by the end of micu course, patient's free water deficit had largely corrected. * acute on chronic renal failure: on admission, patient's creatinine was 2.7, thought to be secondary to hypoperfusion during bradycardic episode. with recovery of hemodynamics, patient's urine output and renal function improved accordingly. course: the patient was called out to the floor from the intensive care unit on thursday . * psych/agitation: she experienced some agitation and getting out of bed although she was unsteady on her feet. she was placed on 1:1 sitter for one night on . * bacterial pneumonia: she completed a 10 day course of vancomycin, levofloxacin, and metronidazole on . she has not experienced any fevers or respiratory difficulty since being called out of the unit and was successfully weaned off of oxygen. * chronic renal failure/hyperkalemia: her renal function has remained at baseline of 0.8-1.2 on the wards without hyperkalemia. she was started on losartan and hydralazine was discontinued (due to concerns for compliance). she will need monitoring of potassium to ensure that hyperkalemia does not recurr on this medication. * hypotension * she experienced no further hypotension and instead experienced hypertension throughout her course on the floor. medications on admission: albuterol prn, asa, avandia, depakote er, diovan, prozac, glucophage, lasix, lipitor, neurontin, serax, seroquel, cartia xt, oxycodone discharge medications: 1. heparin sodium (porcine) 5,000 unit/ml solution sig: one (1) ml injection tid (3 times a day). 2. divalproex sodium 500 mg tablet sustained release 24hr sig: two (2) tablet sustained release 24hr po qhs (once a day (at bedtime)). 3. fluoxetine hcl 20 mg capsule sig: one (1) capsule po daily (daily). 4. acetaminophen 325 mg tablet sig: 1-2 tablets po q4-6h (every 4 to 6 hours) as needed. 5. docusate sodium 150 mg/15 ml liquid sig: fifteen (15) ml po bid (2 times a day). 6. senna 8.8 mg/5 ml syrup sig: one (1) tablet po bid (2 times a day). 7. bisacodyl 5 mg tablet, delayed release (e.c.) sig: two (2) tablet, delayed release (e.c.) po daily (daily) as needed. 8. aspirin 325 mg tablet sig: one (1) tablet po daily (daily). 9. gabapentin 300 mg capsule sig: one (1) capsule po daily (daily). 10. bisacodyl 10 mg suppository sig: one (1) suppository rectal hs (at bedtime) as needed. 11. albuterol sulfate 0.083 % solution sig: one (1) treatment inhalation q4h (every 4 hours) as needed for shortness of breath or wheezing. 12. quetiapine fumarate 100 mg tablet sig: one (1) tablet po bid (2 times a day). 13. pantoprazole sodium 40 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po q24h (every 24 hours). 14. quetiapine fumarate 25 mg tablet sig: 0.5 tablet po q12h (every 12 hours) as needed. 15. ipratropium bromide 0.02 % solution sig: one (1) treatment inhalation q4h (every 4 hours) as needed for shortness of breath or wheezing. 16. insulin nph human recomb 100 unit/ml suspension sig: twenty four (24) units subcutaneous q am. 17. insulin nph human recomb 100 unit/ml suspension sig: twelve (12) units subcutaneous at bedtime. 18. furosemide 40 mg tablet sig: 1.5 tablets po daily (daily). 19. lactulose 10 g/15 ml syrup sig: thirty (30) ml po q8h (every 8 hours) as needed. 20. metoprolol succinate 25 mg tablet sustained release 24hr sig: one (1) tablet sustained release 24hr po daily (daily). 21. diltiazem hcl 240 mg capsule, sustained release sig: one (1) capsule, sustained release po daily (daily). 22. losartan potassium 25 mg tablet sig: one (1) tablet po daily (daily). discharge disposition: extended care facility: - discharge diagnosis: bradycardia hypotension bacterial pneumonia sepsis hypernatremia acute renal failure chronic renal failure discharge condition: good discharge instructions: please take all of your medications as prescribed. if you experience shortness of breath, chest pain, worsening cough or fevers, call your doctor or return to the emergency department. followup instructions: please follow up with your primary care doctor below on th. provider: , medicine (private) where: adult medicine unit healthcare - 1000 - , phone: date/time: 11:30 md procedure: continuous invasive mechanical ventilation for less than 96 consecutive hours venous catheterization, not elsewhere classified insertion of endotracheal tube enteral infusion of concentrated nutritional substances non-invasive mechanical ventilation transfusion of packed cells infusion of vasopressor agent diagnoses: hyperpotassemia nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere congestive heart failure, unspecified acute kidney failure, unspecified other pulmonary insufficiency, not elsewhere classified unspecified septicemia severe sepsis infection with microorganisms resistant to penicillins hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other specified cardiac dysrhythmias pneumonitis due to inhalation of food or vomitus septic shock methicillin susceptible pneumonia due to staphylococcus aureus hyperosmolality and/or hypernatremia benzodiazepine-based tranquilizers causing adverse effects in therapeutic use diabetes with renal manifestations, type ii or unspecified type, uncontrolled paranoid type schizophrenia, unspecified coronary vasodilators causing adverse effects in therapeutic use 

Answer: The patient is high likely exposed to